A $1.9 Billion Buyout, Two Insider Bets, and a Micro-Cap Reversal — The Stocks to Watch Tomorrow

Wall Street closed out the week with a relief rally Friday as in-line inflation data eased fears of an aggressive Fed move, but the real fireworks Friday were happening far away from the mega-caps. A $1.9 billion buyout, a UBS “Sell” call on a nuclear darling, two separate CEO insider-buying bets, and a micro-cap that went from a 37% crash to a 52% surge in the span of 24 hours all made headlines — and all of it sets up a busy Monday for traders. Here are the 10 top stocks to watch tomorrow, deliberately skipping the usual mega-cap suspects in favor of the smaller names actually moving on real news.

1. ACV Auctions (ACVA) | Closed at $10.41, Up 44.18% on a $1.9B Buyout

Copart Just Bought Its Way Into Digital Car Auctions

ACV Auctions delivered the cleanest story of the week: a definitive, all-cash acquisition that instantly reprices the stock to its takeout value.

Full Data & Snapshot:

Catalyst & News: Copart agreed to acquire ACV Auctions for $10.50 per share in cash, valuing the digital vehicle-auction platform at approximately $1.9 billion — a roughly 45% premium to ACV’s unaffected August 10 closing price and a 41% premium to its 30-day volume-weighted average price. Both boards unanimously approved the deal, which Copart plans to fund entirely with cash on hand, with closing targeted for the end of 2026 pending antitrust review. Law firm Halper Sadeh LLC has since announced it’s reviewing whether the board secured a fair price, a routine step in nearly every public-company buyout.

Technicals: With shares closing at $10.41 — just nine cents below the $10.50 deal price — the stock is now trading almost purely as a merger-arbitrage instrument. Resistance sits at the $10.50 deal price itself, a ceiling the stock is unlikely to meaningfully clear absent a competing bid. Support sits near $10.00–$10.20, the level where arbitrage funds have been active buyers.

Bull Case: Barring a regulatory objection, this is close to a locked-in return for anyone buying below $10.50, and any hint of a competing bidder emerging before the deal closes could push shares meaningfully higher.

Bear Case: Antitrust review of Copart’s expansion into vehicle remarketing could drag on or, in a worst case, block the deal outright, which would send ACVA shares sharply back toward its pre-deal price in the $7 range.

Forecast: Expect a tight, low-volatility trading range just under $10.50 through the rest of 2026 as the market prices in a high probability of deal completion.

2. NuScale Power (SMR) | Closed at $8.61, Down 15.67% on a UBS Sell Call

Wall Street’s Favorite Nuclear Story Just Got a Reality Check

NuScale Power, the only small modular reactor developer with full NRC design certification, took its sharpest hit of the year after a blunt downgrade from UBS.

Full Data & Snapshot:

Catalyst & News: UBS downgraded NuScale to Sell from Neutral and slashed its price target to $6 from $10, forecasting roughly $700 million in cumulative cash burn from 2026 through 2028 and warning that profitability isn’t likely until after 2030. The bank now assumes only one NuScale project breaks ground in 2028, citing slow progress on the Tennessee Valley Authority partnership and complications with the RoPower initiative in Romania. The stock’s Q2 revenue of just $0.07 million — badly missing an $8.8 million estimate — underscored the gap between regulatory approval and actual contracted revenue.

Technicals: Shares broke down from a recent $9–$10 consolidation zone to touch $8.57 intraday, on volume nearly 200% above the daily average. Immediate support sits at the July 17 record low of $7.21 — a level that would confirm the multi-week uptrend has fully reversed if breached. Resistance now sits at $9.72–$10.00, the shelf the stock broke down from this week.

Bull Case: NuScale remains the only U.S. developer with a fully certified SMR design, holds nearly $1.9 billion in cash providing years of runway, and any binding contract announcement — particularly around AI-driven data center power demand — could spark a sharp short-covering rally given the stock’s high 11%+ short interest in the group.

Bear Case: UBS’s math is hard to argue with: minimal revenue, no firm module orders, and a profitability timeline pushed out past 2030 make this a story stock trading on regulatory milestones rather than fundamentals.

Forecast: Watch the $7.21 level closely — a break below it likely accelerates selling toward single digits, while a bounce and reclaim of $9.72 would suggest the sell-off was overdone.

3. Alphatec Holdings (ATEC) | Closed at $10.58, Up 19.68% on a $1 Million CEO Bet

The Spine-Surgery Stock Its Own CEO Just Backed With Real Money

Alphatec surged after CEO Patrick Miles put more than $1 million of his own capital behind the stock near multi-year lows.

Full Data & Snapshot:

Catalyst & News: CEO Patrick Miles disclosed an open-market purchase of 115,000 shares totaling roughly $1.01 million at a weighted average price of $8.81, executed September 10 — just before the stock’s near-52-week low of $6.82. The timing and size of the buy sent a strong signal of insider conviction, and shares climbed as high as $10.54 intraday before settling near $10.58.

Technicals: ATEC has now rallied approximately 14.7% over the past month, though it remains down roughly 37.6% over the trailing 12 months. Resistance sits at $11.71–$12.00, a prior consolidation shelf from earlier this summer, with stronger resistance near $16.68, the current average analyst price target. Support sits at $9.35, Friday’s intraday low, with deeper support at the $6.82 52-week low.

Bull Case: The average analyst price target of $16.68 implies roughly 58% upside from Friday’s close, revenue continues to beat estimates, and a CEO willing to deploy seven figures of personal capital near multi-year lows is a historically reliable signal in medtech names.

Bear Case: The stock has lagged the broader market badly over the past year, carries a “somewhat weak” fundamental rating from independent screeners, and 11.3% short interest suggests real skepticism remains about the path to sustained profitability.

Forecast: A confirmed close above $11.71 would open the door toward the $16–$17 analyst target zone; failure to hold above $9.35 would suggest Friday’s insider-driven pop faded quickly.

4. Frequency Electronics (FEIM) | Closed at $88.38, Up 42.40% on Record Earnings

A Defense-and-Space Timing Supplier Just Posted Its Best Quarter Ever

Frequency Electronics, a niche supplier of precision timing and frequency-control products for satellites and defense systems, more than doubled its year-ago revenue and the stock responded violently.

Full Data & Snapshot:

Catalyst & News: Frequency Electronics reported first-quarter fiscal 2027 revenue of $23.5 million, an all-time record, up 70% year-over-year and 52% sequentially, driven by record backlog and strength in both space and defense end markets. CEO Tom McClelland highlighted the results as evidence of a broader multi-year growth trajectory, with management pointing to a targeted 34% revenue CAGR and significant margin expansion by fiscal 2029. The company completed a $73 million capital raise earlier this summer to fund the growth ramp.

Technicals: Shares gapped up from Thursday’s close to open around $81.20 pre-market before climbing through the session to $88.38, a move that has now pushed the stock well above its already-elevated 50-day moving average. Support sits at $81.20, Friday’s opening print, with deeper support near $75. Resistance is essentially uncharted territory above the current price, though the $81 analyst target — now well below the stock’s actual trading level — suggests upgrades are likely imminent.

Bull Case: Record backlog, 70% revenue growth, and expanding margins in structurally growing space and defense end markets give this small-cap real fundamental momentum, not just a headline-driven pop.

Bear Case: Short interest stood at 11.39% of the float as of late August, production constraints could limit how quickly backlog converts to revenue, and the stock’s parabolic one-day move increases the risk of a sharp mean-reversion pullback.

Forecast: Watch for analyst price-target updates early next week — the current $81 average target is already stale relative to Friday’s close, and upward revisions could either validate the move or signal it’s gotten ahead of itself.

5. CPI Card Group (PMTS) | Closed at $22.50, Down 16.48% on a Secondary Offering

A Red-Hot August Rally Meets a Reality Check From Insiders Cashing Out

CPI Card Group, a payments-technology company that had soared 37.5% in August, gave back nearly all of those gains after existing shareholders priced a big secondary offering below market.

Full Data & Snapshot:

Catalyst & News: Stockholders affiliated with Parallel49 Equity priced a secondary offering of 2,337,323 shares at $21.50 — about 20% below Thursday’s closing price — with the deal expected to close around September 14. CPI itself will not receive any proceeds from the sale, which is purely existing shareholders monetizing their stake, but the below-market pricing and share-count increase weighed heavily on sentiment just weeks after the stock’s blowout August rally on strong free cash flow.

Technicals: Shares fell as low as $21.90 intraday before recovering slightly to close at $22.50. Immediate support sits at the $21.50 offering price, which should act as a psychological floor unless fresh negative news emerges. Resistance sits at $24–$25, roughly where shares traded before Thursday’s announcement, with major resistance at the 52-week high of $31.25.

Bull Case: The underlying business generated $25.9 million in free cash flow last quarter, two analysts raised price targets to $32–$34 just last month, and secondary offerings by existing holders — as opposed to new company-issued shares — don’t dilute the business itself.

Bear Case: A 20%-below-market secondary pricing signals insiders were eager to lock in gains after the August rally, and the stock’s round-trip from a 37.5% monthly gain back to near-flat shows how quickly sentiment can reverse in thinly traded small-caps.

Forecast: A stabilization above the $21.50 offering price into next week would suggest the sell-off is done; a break below it would raise questions about whether the insider selling reflects concerns beyond simple profit-taking.

6. GT Biopharma (GTBP) | Closed at $8.61, Up 39.32% on a Company Webinar

A Micro-Cap Cancer Biotech Rallies Into Its Own Investor Presentation

GT Biopharma, a clinical-stage immuno-oncology company, jumped sharply ahead of and during a live webinar detailing progress on its natural killer cell-engager platform.

Full Data & Snapshot:

Catalyst & News: GT Biopharma hosted a live company presentation Friday afternoon titled “The TriKE Platform, Clinical Progress, and the Case for NK Cell Immunotherapy,” featuring CEO Michael Breen and consulting senior medical director Dr. Jeffrey Miller. The webinar covered clinical progress in blood cancers and solid tumors, dose-escalation insights, and competitive positioning for the company’s TriKE (Tri-specific Killer Engager) platform. The event follows a September 3 reverse stock split completed to streamline the company’s capital structure and a Buy rating from Roth MKM issued in mid-August.

Technicals: With average volume typically near 244,000 shares, Friday’s 544,275-share turnout represents more than double the norm — a clear sign of event-driven interest. Resistance sits near $10–$11, levels the stock hasn’t sustained since its post-reverse-split debut. Support sits at $6–$6.50, the pre-webinar trading range.

Bull Case: A Strong Buy consensus and $11 price target from covering analysts, combined with active dosing across multiple trials and growing hedge fund interest, suggest real institutional attention despite the company’s tiny size.

Bear Case: As a pre-revenue clinical-stage biotech, GTBP remains entirely dependent on trial outcomes and is subject to binary risk — any disappointing data readout could erase this rally and then some, and the recent reverse split itself reflects a depressed share price the company had to address.

Forecast: Watch for follow-through buying into next week as investors digest webinar commentary — sustained volume above the recent average would suggest the rally has legs beyond a single-day news pop.

7. CVD Equipment (CVV) | Closed at $4.68, Down 25.36% on a Major Restructuring

A Cash-Rich Equipment Maker Slams the Brakes on Its Core Business

CVD Equipment shares were cut by roughly a quarter after the company announced it would stop pursuing new orders for its namesake equipment business entirely.

Full Data & Snapshot:

Catalyst & News: CVD Equipment announced it will halt new system orders for its core CVD equipment business, cut its workforce by roughly 50%, and take a $0.8–$1.0 million restructuring charge this quarter. CEO Emmanuel Lakios departed the company effective September 3, with VP of Manufacturing Operations Warren Cheesman stepping in as Acting CEO. Going forward, the company will focus solely on completing its existing backlog, warranty obligations, and its parts, quartz, and service businesses while the board evaluates other strategic paths.

Technicals: Volume of over 844,000 shares ran more than six times the three-month average of roughly 130,000, confirming a decisive, high-conviction sell-off rather than routine profit-taking. Support sits at $4.00–$4.20, a level from earlier this summer before the stock’s 2026 rally began. Resistance sits at $6.27, Thursday’s pre-announcement close.

Bull Case: A debt-free balance sheet with $23.5 million in cash against a $32.5 million market cap gives CVD real staying power to explore strategic alternatives, and the stock remains up over 100% over the trailing 12 months despite Friday’s drop.

Bear Case: Walking away entirely from new orders in your core business is a rare and drastic step that signals management sees no near-term path to profitable growth in that segment, and the company currently lacks traditional Wall Street analyst coverage to provide an independent read on the pivot.

Forecast: With no clear replacement strategy yet articulated beyond “assessing other business paths,” CVV is likely to trade as a asset-value story tied to its cash hoard until management provides more clarity on next steps.

8. MKDWELL Tech (MKDW) | Closed at $7.75, Up 51.96% in a Stunning Reversal

From a 37% Crash to a 52% Rip — All in Three Trading Days

Just three sessions after cratering on a disappointing earnings report, MKDWELL Tech staged one of the most dramatic reversals of the month on fresh acquisition news.

Full Data & Snapshot:

Catalyst & News: MKDWELL Tech surged after disclosing the completion of its acquisition of Landvision Inc., an AI-driven smart-home company, in a roughly $240 million share deal first announced in July. The Taiwan-based auto-electronics microcap — which crashed 37% on September 10 after a disappointing quarterly report showing just $0.77 million in revenue — is now pivoting hard into smart-home and IoT technology. The same day, the company also launched a $100 million at-the-market share offering with Maxim Group, giving it fresh capital to fund the pivot but also introducing meaningful dilution risk.

Technicals: After bottoming near $5.09 intraday, shares rocketed to a high of $8.58 before settling at $7.75 — extraordinary volatility even by this stock’s already-volatile standards (65.6% historical volatility, per TradingView data). Resistance sits at $8.58, Friday’s intraday high, with major resistance at the 52-week high of $12.94. Support sits at $5.09–$6.00, Friday’s low and the pre-rally consolidation zone.

Bull Case: The Landvision acquisition gives MKDWELL genuine diversification beyond its struggling auto-electronics business into the growing smart-home and IoT space, and a hedge fund (Citadel Advisors) has already disclosed a new stake in the name.

Bear Case: The newly launched $100 million at-the-market offering — nearly three times the company’s entire market cap — represents massive potential dilution, and a company that just posted negative shareholder equity and under $1 million in quarterly revenue faces a steep credibility climb regardless of the new acquisition’s promise.

Forecast: This remains one of the most speculative, headline-driven names on the market — expect continued outsized volatility as the Landvision integration and ATM offering both play out in real time over the coming weeks.

9. America’s Car-Mart (CRMT) | Closed at $1.90, Up 19.50% on a Shocking Earnings Beat

A Company Bloomberg Said Might Wind Down Just Posted a Massive Profit Beat

America’s Car-Mart, a used-vehicle retailer that spent the summer fighting off both a potential wind-down and a securities class-action investigation, shocked the market with a dramatic earnings beat.

Full Data & Snapshot:

.

Catalyst & News: America’s Car-Mart reported first-quarter fiscal 2027 adjusted EPS of $1.64, obliterating the consensus estimate of a $0.77 per-share loss — one of the largest earnings surprises of the week across the entire market. The beat comes just days after the company secured a short-term extension of a credit waiver amid an ongoing strategic review, following a July Bloomberg report that the company was exploring asset sales and could potentially wind down entirely. Multiple law firms, including Rosen Law Firm, have separately been investigating potential securities claims on behalf of investors tied to the company’s prior disclosures.

Technicals: Shares are down more than 94% from their 52-week high of $35.50, reflecting just how distressed this situation has become, but Friday’s move on nearly three million shares of volume — roughly five times the daily average — shows real buying conviction. Resistance sits at $2.14, Friday’s intraday high, with next resistance at $3.00. Support sits at $1.54, Friday’s intraday low, with the 52-week low of $1.37 as a critical floor.

Bull Case: A profit beat of this magnitude, combined with a successfully extended lender waiver, suggests the company may have more operational stability than the wind-down headlines implied, and the stock’s tiny market cap means even modest good news can produce outsized percentage moves.

Bear Case: This remains a company that was reportedly exploring a full wind-down just two months ago, faces active securities-fraud litigation risk, and one strong quarter doesn’t resolve the underlying credit and capital-structure issues that put it in this position in the first place.

Forecast: This is a binary, high-risk turnaround story — a confirmed break above $2.14 and continued lender cooperation would be the first real signs of stabilization, while any negative update on the credit waiver situation could quickly erase Friday’s gains.

10. HUB Cyber Security (HUBC) | Closed at $0.341, Down 18.21% Into Its Reverse Split

The Fallout From Thursday’s Emergency Split Continues

HUB Cyber Security extended its losses for a second straight session as the company’s previously announced reverse stock split took effect.

Full Data & Snapshot:

Catalyst & News: HUB Cyber Security’s 1-for-25 reverse stock split took effect Friday, consolidating roughly 44.9 million outstanding shares into approximately 1.8 million, following Thursday’s announcement of the move designed to maintain Nasdaq listing compliance. Split-adjusted trading fully begins September 14, meaning Monday will be the first full session reflecting the new, consolidated share count — a key reason this name stays on the radar heading into the new week.

Technicals: With the stock still finding its footing around the reverse-split mechanics, traditional support and resistance levels are less meaningful until Monday’s split-adjusted open establishes a clean baseline. Watch for a stabilization test in the first hour of Monday trading as the market fully digests the new share count.

Bull Case: A successfully executed reverse split could reduce the sub-$1 stigma that keeps institutional investors away, and any positive contract news in HUB’s confidential-computing business could attract fresh attention now that the share-count issue is resolved.

Bear Case: Reverse splits address a symptom, not a cause — this is the company’s second major capital-structure move in roughly a year, and continued weakness following the split would suggest the underlying business challenges remain unresolved.

Forecast: Monday’s open is the single most important session to watch for this name — a stable or higher open on the new share count would be a modestly encouraging sign, while continued heavy selling would suggest the reverse split hasn’t restored investor confidence.

At a Glance: Stocks to Watch Tomorrow

Follow TNN for daily stock market news and financial news today. Get daily stocks to watch tomorrow watchlist.

Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and small-cap, high-volatility stocks like those featured above carry elevated risk. Stock prices, percentage moves, technical levels, and market data cited reflect figures available at the time of publication and are subject to change as trading continues. Analyst price targets and ratings are third-party estimates and do not guarantee actual results. Always complete independent due diligence prior to executing equity trades.

About The Author

Kasia Davis

See author's posts